Abstract
Currently, the nutraceutical approach to treat dyslipidaemia is increasing in use, and in many cases is used by physicians as the first choice in the treatment of patients with borderline values. Nutraceuticals represent an excellent opportunity to treat the preliminary conditions not yet showing the pathological signs of dyslipidaemia. Their general safety, the patient’s confidence, the convincing proof of efficacy and the reasonable costs prompted the market of new preparations. Despite this premise, many nutraceutical products are poorly formulated and do not meet the minimum requirements to ensure efficacy in normalizing blood lipid profiles, promoting cardiovascular protection, and normalizing disorders of glycemic metabolism. In this context, bioaccessibility and bioavailability of the active compounds is a crucial issue. Little attention is paid to the proper formulations needed to improve the overall bioavailability of the active molecules. According to these data, many products prove to be insufficient to ensure full enteric absorption. The present review analysed the literature in the field of nutraceuticals for the treatment of dyslipidemia, focusing on resveratrol, red yeast rice, berberine, and plant sterols, which are among the nutraceuticals with the greatest formulation problems, highlighting bioavailability and the most suitable formulations.
Subject
Food Science,Nutrition and Dietetics
Reference182 articles.
1. Current Prospects of Nutraceuticals: A Review;Curr. Pharm. Biotechnol.,2020
2. Role of nutraceuticals in human health;J. Food Sci. Technol.,2012
3. New concepts in nutraceuticals as alternative for pharmaceuticals;Int. J. Prev. Med.,2014
4. Nutraceutical Support in Heart Failure: A Position Paper of the International Lipid Expert Panel (ILEP);Nutr. Res. Rev.,2020
5. Nutraceuticals in Parkinson’s Disease;Neuromol. Med.,2016
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献